Prolific Machines vs Karius

Side-by-side comparison of AI visibility scores, market position, and capabilities

Karius leads in AI visibility (73 vs 35)
Prolific Machines logo

Prolific Machines

EmergingLife Sciences & BioTech

Light-Activated Cell Growth & Biomanufacturing Technology

Prolific Machines is a Berkeley-based biotech company using light to control cell growth and differentiation, dramatically reducing bioreactor costs for cultivated meat and cell therapy; raised $55M+ including a $36M Series B in 2023;

AI VisibilityBeta
Overall Score
D35
Category Rank
#142 of 198
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
37
Perplexity
30
Gemini
34

About

Prolific Machines is a Berkeley, California-based biomanufacturing technology company founded in 2020 by Deniz Kent, Joshua Mich, and Declan Jones that has developed a pioneering approach to cell biology: using light — specifically engineered light-sensitive proteins (optogenetics) — to control the growth and differentiation of stem cells and other mammalian cells in bioreactors. Traditional cell culture requires expensive biological growth factors (proteins such as FGF2 and TGF-β) added to culture media to drive cell proliferation and differentiation. Prolific Machines'' technology replaces or dramatically reduces the need for these expensive growth factor inputs by using light signals to activate engineered receptors within cells — achieving the same biological responses at a fraction of the cost.

Full profile
Karius logo

Karius

LeaderLife Sciences & BioTech

Genomic Infectious Disease Diagnostics

Karius raised $409M total including a $100M Series C in May 2024; its genomic blood test detects 1,000+ pathogens at 400+ U.S. hospitals; launched Karius Focus BAL for pneumonia in April 2025.

AI VisibilityBeta
Overall Score
B73
Category Rank
#12 of 198
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
69
Perplexity
70
Gemini
70

About

Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens (bacteria, fungi, viruses, parasites) in seriously ill patients. The test is used when conventional cultures and targeted diagnostics fail, providing clinicians at transplant centers, children''s hospitals, and ICUs with a comprehensive pathogen report within 24 hours.

Full profile

AI Visibility Head-to-Head

35
Overall Score
73
#142
Category Rank
#12
79
AI Consensus
78
stable
Trend
stable
37
ChatGPT
69
30
Perplexity
70
34
Gemini
70
39
Claude
75
34
Grok
77

Key Details

Category
Light-Activated Cell Growth & Biomanufacturing Technology
Genomic Infectious Disease Diagnostics
Tier
Emerging
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.